Lipoproteins
Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With Fenofibrate
Marja-Riitta Taskinen, David R. Sullivan, Christian Ehnholm, Malcolm Whiting, Diana Zannino, R. John Simes, Anthony C. Keech, Philip J. Barter
and for the FIELD study investigators
https://doi.org/10.1161/ATVBAHA.108.178228
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;
Originally published March 26, 2009Marja-Riitta Taskinen
David R. Sullivan
Christian Ehnholm
Malcolm Whiting
Diana Zannino
R. John Simes
Anthony C. Keech

This is a PDF-only article. The first page of the PDF of this article appears below.

Current Issue
Article Tools
- Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With FenofibrateMarja-Riitta Taskinen, David R. Sullivan, Christian Ehnholm, Malcolm Whiting, Diana Zannino, R. John Simes, Anthony C. Keech and Philip J. Barter for the FIELD study investigatorsArteriosclerosis, Thrombosis, and Vascular Biology. 2009;, originally published March 26, 2009https://doi.org/10.1161/ATVBAHA.108.178228
Citation Manager Formats
Share this Article
- Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With FenofibrateMarja-Riitta Taskinen, David R. Sullivan, Christian Ehnholm, Malcolm Whiting, Diana Zannino, R. John Simes, Anthony C. Keech and Philip J. Barter for the FIELD study investigatorsArteriosclerosis, Thrombosis, and Vascular Biology. 2009;, originally published March 26, 2009https://doi.org/10.1161/ATVBAHA.108.178228